论文部分内容阅读
目的:观察增抗宁口服液治疗儿童感染相关粒细胞减少症的临床疗效。方法:100例随机分为两组各50例,两组均采用常规对症治疗,对照组给予常规治疗,治疗组在对照组治疗的基础上加服匹多莫德口服液治疗,对比2组临床疗效。结果:治疗组总有效率为96.0%高于对照组的86.0%,差异有统计学意义(P<0.05)。治疗组白细胞计数与中性粒细胞绝对值计数恢复正常时间短于对照组(P<0.05)。结论:增抗宁口服液治疗儿童感染相关粒细胞减少症疗效确切,且较为安全。
Objective: To observe the clinical efficacy of Zengkangning oral liquid in the treatment of infection-related granulocytopenia in children. Methods: One hundred cases were randomly divided into two groups of 50 cases. Both groups were treated with routine symptomatic treatment. The control group was given routine treatment. The treatment group was treated with Pidotimod oral solution on the basis of the control group. Efficacy. Results: The total effective rate in the treatment group was 96.0% higher than that in the control group (86.0%), the difference was statistically significant (P <0.05). The recovery time of white blood cell count and neutrophil absolute count in treatment group were shorter than those in control group (P <0.05). Conclusion: Zengkunning oral solution for children with infection-related neutropenia curative effect is accurate, and more secure.